Harnessing AlphaFold to reveal hERG channel conformational state secrets

Khoa Ngo,Pei-Chi Yang,Vladimir Yarov-Yarovoy,Colleen E. Clancy,Igor Vorobyov
DOI: https://doi.org/10.1101/2024.01.27.577468
2024-10-25
Abstract:To design safe, selective, and effective new therapies, there must be a deep understanding of the structure and function of the drug target. One of the most difficult problems to solve has been resolution of discrete conformational states of transmembrane ion channel proteins. An example is K 11.1 (hERG), comprising the primary cardiac repolarizing current, . hERG is a notorious drug anti-target against which all promising drugs are screened to determine potential for arrhythmia. Drug interactions with the hERG inactivated state are linked to elevated arrhythmia risk, and drugs may become trapped during channel closure. However, the structural details of multiple conformational states have remained elusive. Here, we guided AlphaFold2 to predict plausible hERG inactivated and closed conformations, obtaining results consistent with multiple available experimental data. Drug docking simulations demonstrated hERG state-specific drug interactions in good agreement with experimental results, revealing that most drugs bind more effectively in the inactivated state and are trapped in the closed state. Molecular dynamics simulations demonstrated ion conduction for an open but not AlphaFold2 predicted inactivated state that aligned with earlier studies. Finally, we identified key molecular determinants of state transitions by analyzing interaction networks across closed, open, and inactivated states in agreement with earlier mutagenesis studies. Here, we demonstrate a readily generalizable application of AlphaFold2 as an effective and robust method to predict discrete protein conformations, reconcile seemingly disparate data and identify novel linkages from structure to function.
Biophysics
What problem does this paper attempt to address?
The key problem that this paper attempts to solve is how to use AlphaFold2 to predict and reveal the structural details of the hERG channel protein in different functional states, especially its closed and inactivated conformations. Specifically: 1. **Understanding the mechanism of drug action**: The hERG channel is the main carrier of the rapid delayed rectifier potassium current (I_Kr) in the heart and plays a crucial role in the repolarization process of cardiomyocytes. The interaction of many drugs with the hERG channel will increase the risk of arrhythmia, especially when the drug binds to the inactivated hERG channel, which may lead to drug retention and further increase the risk of arrhythmia. Therefore, understanding the specific structure of the hERG channel in these states is crucial for the design of safe and effective drugs. 2. **Capturing multiple conformational states**: Although experimental techniques such as cryo - EM have provided high - resolution structures of the open state of the hERG channel, the structures of the closed and inactivated states are still elusive. Although traditional molecular dynamics simulations can sample different conformations, due to limitations in time scale and computational resources, they usually cannot observe meaningful conformational changes. In addition, enhanced sampling simulation techniques may introduce biases, causing the protein to enter non - physiological conformations. Therefore, how to accurately predict these dynamic conformational states is an urgent problem to be solved. 3. **Verifying the application potential of AlphaFold2**: AlphaFold2, as a protein structure prediction tool based on deep learning, has achieved remarkable success in the prediction of a single static conformation. However, AlphaFold2 in the default configuration can only generate a single - state structure. In this study, by introducing a new modeling strategy to guide AlphaFold2 to predict multiple physiologically relevant conformations, this limitation is overcome. Through this method, researchers can generate structural models of the hERG channel in different functional states and verify these prediction results through drug docking simulations and molecular dynamics simulations to ensure that they are consistent with experimental data. In summary, this paper aims to use AlphaFold2 to reveal the structural details of the hERG channel in different functional states, providing a more comprehensive understanding and support for drug design and safety assessment.